Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-09-19
1999-11-09
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 27, 536 41, 549200, 549356, 549416, 549423, 549 13, 549 62, 549 64, 549 66, A61K 3135, C07D30936, C07D30940
Patent
active
059814969
ABSTRACT:
Novel .alpha.-pyrones are described. The .alpha.-pyrones are useful in a method for controlling .alpha.-pyrone responsive states in a mammal. The method includes administering to a mammal a therapeutically effective amount of an .alpha.-pyrone such that control of .alpha.-pyrone responsive states in a mammal occurs. .alpha.-Pyrone responsive states can be associated with undesirable cell proliferation such as bacteria or cancer. Packaged pharmaceuticals and pharmaceutical compositions including the novel .alpha.-pyrones are also described.
REFERENCES:
patent: 3973945 (1976-08-01), Fujino et al.
patent: 4992271 (1991-02-01), Fernandes et al.
patent: 5314685 (1994-05-01), Praveen et al.
Evidente et al., (CA 121:276292, abstract of Nat. Toxins (1994), 2(1), 4-13.
Visconti et al. (CA 121:200529, abstract of J. Nat. Prod. (1994), 57(6), 695-9.
Brienholt et al. (CA 120:52828, abstract of WO 9322444), 1993.
Berge, S.M., et al., "Pharmaceutical Salts", J. Pharm. Sci., 66:1-19 (1977).
Poulton, G.A., and Cyr, T.D., "Pyrones. VI. The total synthesis of phacidin", Can. J. Chem., 58:2158-2160 (1980).
Groutas, W.C., et al., "Substituted 2-Pyrones, 2-Pyridones, and Other Congeners of Elasnin as Potential Agents for the Treatment of Chronic Obstructive Lung Diseases", Journal of Medicinal Chemistry, 28:1106-1109 (1985).
Wang, C.-S., "Structure and Chemistry of 4-Hydroxy-6-methyl-2-pyridone", J. Heterocycl. Chem., 7:389-392 (1970).
Spencer, R.W., et al., "Inhibition of Human Leukocyte Elastase, Porcine Pancreatic Elastase, and Chymotrypsin by Elasnin and Other 4-Hydroxy-2-pyrones", J. Med. Chem., 28:1828-1832 (1985).
Groutas, W.C., et al., "Specific inhibition of human leukocyte elastase by substituted alpha-pyrones", Experientia, 40:361-362 (1984).
Omura, S., et al., "Elasnin, A New Human Granulocyte Elastase Inhibitor Produced By A Strain of Streptomyces", Biochemical and Biophysical Research Communications, 83:704-709 (1978).
Banfalvi, G. and Sarkar, N., "Origin and Degradation of the RNA Primers at the 5' Termini of Nascent DNA Chains in Bacillus subtilis", J. Mol. Biol. 186:275-282 (1985).
Higgins, N.P., et al., "Bacteriophase Mu DNA Replication in Vitro", The Journal of Biological Chemistry, 258:4293-4297 (1983).
Dunn, J.J. and Studier, F.W., "Nucleotide Sequence from the Genetic Left End of Bacteriophase T7 DNA to the Beginning of Gene 4", J. Mol. Biol. 148:303-330 (1981).
Munson, B.R., et al., "Segregation of Relaxed Replicated Dimers When DNA Ligase and DNA Polymerase I Are Limited during oriC-Specific DNA Replication", Journal of Bacteriology, 171:3803-3809 (1989).
Ciarrocchi, G., et al., "Correlation between anthracycline structure and human DNA ligase inhibition", Biochem. J. 279:141-146 (1991).
Yang, S-W, et al., "Identification of a specific inhibitor for DNA ligase I in human cells", Proc. Natl. Acad. Sci. USA, 89:2227-2231 (1992).
David, J-C, et al., "Inhibition of DNA Ligase from Human Thymocytes and Normal or Leukemic Lymphocytes by Antileukemic Drugs", Cancer Research, 45:2177-2183 (1985).
Tan, G.T., et al., "Natural-product inhibitors of human DNA ligase I", Biochem. J., 314:993-1000 (1996).
Barnes, D.E., et al., "Human DNA ligase I cDNA: Cloning and functional expression in Saccharomyces cerevisiae", Proc. Natl. Acad. Sci. USA, 87:6679-6683 (1990).
Shuman, S. and Schwer, B., "RNA capping enzyme and DNA ligase: a superfamily of covalent nucleotidyl transferases", Molecular Microbiology, 17(3):405-410 (1995).
Kodama, K-i, et al., "In vitro mutagenesis and functional expression in Escherichia coli of a cDNA encoding the catalytic domain of human DNA ligase I", Nucleic Acids Research, 19:6093-6099 (1991).
Subramanya, H.S., et al., "Crystal Structure of an ATP-Dependent DNA Ligase from Bacteriophase T7", Cell, 85:607-615 (1996).
Cohen Seth
Jiang Zhi-Dong
Dees Jos,e G.
Hanley Elizabeth A.
Millennium Pharmaceutical, Inc.
Qazi Sabiha N.
LandOfFree
.alpha.-pyrones for treating .alpha.-pyrone responsive states does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .alpha.-pyrones for treating .alpha.-pyrone responsive states, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha.-pyrones for treating .alpha.-pyrone responsive states will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456032